S. Lagakos. The New England journal of medicine, 355 (2):
113-7(July 2006)4860<m:linebreak></m:linebreak>LR: 20071115; JID: 0255562; 0 (Cyclooxygenase 2 Inhibitors); 0 (Lactones); 0 (Sulfones); 0 (rofecoxib); CON: N Engl J Med. 2005 Mar 17;352(11):1092-102. PMID: 15713943; 2006/06/26 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
P. Andersen, and N. Keiding. Statistics in medicine, 31 (11-12):
1074-88(May 2012)6439<m:linebreak></m:linebreak>CI: Copyright (c) 2011; JID: 8215016; aheadofprint;<m:linebreak></m:linebreak>Anàlisi de supervivència; Competing risks.